ÎçÒ¹¾ç³¡

ÎçÒ¹¾ç³¡

Clinical Research on First-In-Human Clinical Trial of Transplantation: Regenerative Medicine Using iPS Cell-Derived Neural Stem/Progenitor Cells to Treat Complete Subacute Spinal Cord Injury

Publish: January 14, 2022
Public Relations Office

January 14, 2022

ÎçÒ¹¾ç³¡ School of Medicine

ÎçÒ¹¾ç³¡ Hospital

A group at ÎçÒ¹¾ç³¡ Hospital has successfully transplanted human iPS cell-derived neural stem/progenitor cells (iPSC-NS/PCs) into the first participant of a clinical study on regenerative medicine using iPSC-NS/PCs for subacute spinal cord injury (SCI).

For further information, please refer to the following PDF file.